Atlas Trials

Extension Study to Study PQ-110-001 (NCT03140969)

Clinical trial NCT03913130 · TERMINATED

Trial details

NCT number
NCT03913130
Sponsor
Laboratoires Thea
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leber Congenital Amaurosis 10BlindnessLeber Congenital AmaurosisVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesEye Diseases, HereditaryEye Disorders CongenitalRetinal Disease
Start date
2019-05-13
Primary completion
2022-10-03
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.